Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology,General Medicine
Reference196 articles.
1. Gottlieb, A. B. Novel immunotherapies for psoriasis: clinical research delivers new hope for patients and scientific advances. J. Invest. Dermatol. Symp. Proc. 9, 79–83 (2004).
2. Gottlieb, A. B. Psoriasis. Dis. Manag. Clin. Outcomes 1, 195–202 (1998).
3. Heydendael, V. M. R. et al. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N. Engl. J. Med. 349, 658–65 (2003).
4. Rapp, S. R., Feldman, S. R., Exum, M. L., Fleischer, A. B. & Reboussin, D. M. Psoriasis causes as much disability as other major medical diseases. J. Am. Acad. Dermatol. 41, 401–407 (1999). This article documents the significant impact of psoriasis on mental and physical well-being.
5. Krueger, G. et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation Patient-Membership Survey. Arch. Dermatol. 137, 280–284 (1998). This article emphasizes the role of quality of life in the assessment of disease severity and response to treatment.
Cited by
133 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献